Clinical Trial Update: Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) [Phase 4]

View source ↗

Summary

This clinical trial update reports the results of a Phase 4 safety study evaluating co-administration of MK-3641 and MK-7243 in adults with seasonal allergic rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• MK-3641
• MK-7243

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinitis, Allergic, Seasonal | Phase 4 | Status: COMPLETED | Results posted: 2016-01-18